Liposomal drug delivery

Recently, liposomal drug delivery systems have come of age, with three antifungal and two anticancer preparations having received final approval for clinical use in a number of countries around the world. A number of other liposomal formulations of drugs, including anticancer, antibacterial and anti-inflammatory drugs, are in early-to-late clinical trials. Ligand- and antibody-targeted applications, designed to further increase site-specific delivery of liposomal drugs, are currently being explored in a number of laboratories.